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The properties of metronidazole/Methocel K4M sustained release floating tablets have been studied 
varying the proportion of the lubricant, stearic acid, on formulations with and without sodium bicarbonate. 
The variables studied include technological properties of the tablets such as tablet hardness and ejection 
pressure, the drug release profile, the hydration kinetics and the floating behaviour. The presence of 
stearic acid and sodium bicarbonate improves the floating behaviour for more than 8 hours. The hydration 
volume, the tablet hardness and the ejection pressure decrease as the stearic acid content increases and 
the polymer content decreases. Drug dissolution increases with increasing proportions of stearic acid 
and decreasing proportions of the polymer in the tablets. The presence of sodium bicarbonate extends 
the differences in dissolution produced by stearic acid. These results are attributed to decreasing matrices 
coherence with an increasing quantity of stearic acid and a reducing polymer proportion. The carbon 
dioxide
 
bubbles produced by sodium bicarbonate expand the matrices facilitating the dissolution, although 
their presence obstructs also the diffusion path through the hydrated gel layer.
Uniterms: Metronidazole. Methocel K4M. Stearic acid. Matrices hydration. Gastric retention. Sodium 
bicarbonate. Sustained release. Drugs/release mechanism.
Estudaram-se as propriedades de comprimidos flutuantes de metronidazol/Methocel K4M de liberação 
controlada, variando-se a proporção do lubrificante, ácido esteárico, nas formulações com e sem 
bicarbonato de sódio. As variáveis estudadas incluem propriedades tecnológicas dos comprimidos, tais 
como dureza, pressão de ejeção, perfil de liberação do fármaco, cinética de hidratação e comportamento 
de flutuação. A presença de ácido esteárico e do bicarbonato de sódio melhora o comportamento de 
flutuação para mais de 8 horas. O volume de hidratação, a dureza e a pressão de ejeção do comprimido 
decrescem à medida que o conteúdo de ácido esteárico e de polímero diminui. A dissolução do fármaco 
aumenta com o aumento das proporções de ácido esteárico e a diminuição das proporções de polímero 
nos comprimidos. A presença de bicarbonato de sódio amplia as diferenças na dissolução produzidas 
pelo ácido esteárico. Estes resultados são atribuídos à coesão decrescente das matrizes, com o aumento 
da quantidade de ácido esteárico e a redução da proporção de  polímero. Bolhas de dióxido de carbono 
produzidas pelo bicarbonato de sódio expandem as matrizes, facilitando a dissolução, embora a presença 
delas obstrua, também, a difusão através da camada de gel hidratado.
Unitermos: Metronidazol. Methocel K4M. Ácido esteárico. Hidratação das matrizes. Retenção gástrica. 
Bicarbonato de sódio. Fármacos/mecanismo de liberação.
INTRODUCTION
Drug delivery systems have been designed in more 
detail with an increasing and better understanding of the 
physicochemical and biological parameters related to their 
behaviour in the organism.
Conventional dosage forms are design to provide 
a given concentration or quantity of the drug in the sys-
temic circulation without any control over drug delivery. 
Controlled-release drug delivery systems provide drug at 
a predetermined, predictable and controlled rate. A major 
constrain in oral controlled drug delivery is that not all 
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drug candidates are absorbed uniformly throughout the 
gastrointestinal tract (GIT). Some drugs are absorbed in 
a particular portion of the GIT only or are absorbed to 
a different extent in various segments of the GIT. Such 
drugs are said to have an absorption window, which iden-
tifies the drug’s primary region of absorption in the GIT. 
An absorption window exists because of physiological, 
physicochemical, or biochemical factors. For instance, 
the pH-dependent solubility and stability level of a drug 
plays an important role in its absorption. The drug must 
be in a solubilised and stable form to successfully cross 
the biological membrane. They can be enough soluble or 
stable only in certain parts of the GIT where they can be 
sufficiently absorbed (Chawla et al., 2003).
Oral sustained release formulations with drugs 
that are not well absorbed throughout the GIT would be 
troublesome. From this point of view, some drugs are 
not amendable to conventional sustained release formu-
lations if they can not be retained in a certain part of the 
gastrointestinal tract favouring an efficient absorption, for 
instance, the stomach (Sheth, Tossounian, 1979). 
In some cases mucoadhesion has been used in the 
gastrointestinal tract to increase the residence time in a 
certain region, in order to improve the systemic absorption 
or for a local effect (Varum et al., 2008).
Intragastric floating systems have been used pharma-
ceutically to deliver active substances for sustained release 
and targeting. Among other, one of the systems that can 
be used to maintain floating a dosage form in the stomach 
is that based on a reduction of the matrices density; faci-
litated by the carbon dioxide resulting from the reaction 
of sodium bicarbonate with an acidic medium like that of 
the stomach (Xu, Groves, 2001; Jiménez-Martínez et al., 
2008; Sriamornsak et al., 2007).
Although some other attempts have been made to 
provide a dosage form with a longer gastrointestinal tran-
sit time, floating delivery systems seem to offer a greater 
safety for clinical uses than some other approaches (Li et 
al., 2002). Gastric floating drug delivery systems are able 
to prolong the stomach retention time of a dosage form, 
thereby improving the local activity, the stability and the 
absorption of the drugs (Li et al., 2001).
Hydrophilic polymers are actually one of the most 
used excipients to control drug delivery from an oral phar-
maceutical dosage form. Hydroxypropyl methylcellulose 
(HPMC) is a polymer often used in the formulation of 
pharmaceutical sustained dosage forms. The mechanisms 
by which it retards drug release include its ability to form 
rapidly a gel layer at the matrix periphery exposed to 
aqueous fluids (Mandal, 1995). The drug is released from 
the matrix mainly by diffusion through water filled pores. 
Consequently, the release rate is associated to porosity 
and tortuosity of the pores and channels network. The 
porosity and tortuosity of a swellable matrix is primarily 
attributed to the swelling ability of the polymer (Efentakis 
et al., 1997).
In spite of the good properties of cellulose derivati-
ves to move smoothly over the inner surfaces of the dies 
where the tablets are compacted, some other formulation 
excipients and drugs can make necessary the use of lu-
bricants to assure a smooth fabrication on the production 
lines. Stearic acid is widely used in oral pharmaceutical 
formulations. It is mainly used in oral formulations as a 
tablet lubricant although it may also be used as a binder 
(Kibbe, 2000).
Stearic acid has been used for the controlled release 
as a dispersion medium of drugs in the form of micros-
pheres made of fats and waxes. The microspheres are 
obtained by the spray and congealing method. Mixtures 
of diclofenac with greasy materials such as glyceryl mo-
nostearate decrease their dissolution rate as the proportion 
of the greasy material in the formulation increases. Con-
trasting, stearic acid seems to permit channelling of the 
drug from the glyceryl monostearate matrix. In this type 
of controlled release formulations a polymeric material 
such as polyvinylpyrrolidone (PVP) has been used as a 
dispersion medium. The increase of the proportion of the 
dispersing agent (PVP) produced an increase of the release 
rate of the drug (Vilivalam, Adeyeye, 1994).
In a similar experimental design, stearic acid has 
been used with hydrophilic excipients to obtain felodipine 
microparticles by the spray and congealing method. In this 
particular case, the effect of the hydrophilic excipients was 
considered of no consequence. The felodipine dissolution 
from matrices containing 50% or more stearic acid attained 
20% after 7 hours (Savolainen, 2003).
Stearic acid has been also used as a binder and vehi-
cle for the controlled release formulation of theophiline. It 
has been used to control the dissolution rate of cylindrical 
dosage forms obtained by extrusion (Grassi et al., 2003).
Theophiline release from tablets made of a mixture 
of hydrophobic granules (one third of stearic acid) and 
granules of a hydrophilic polymer (HPMC) shows that the 
dissolution rate decreases progressively as the hydropho-
bic portion of the mixture increases from 10% to 90% of 
the total weight of the tablets (Hayashi, 2005).
Metronidazole has been selected as a model drug 
for floating tablets with a probable gastric retention, be-
cause of a general assent about the benefits of eradication 
of H. pylori in patients with peptic ulcer. The treatments 
include antibacterials such as bismuth salts, amoxicillin, 
macrolides, tetracycline and nitroimidazoles such as me-
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tronidazole and tinidazole (González et al., 2001). Drugs 
administered systemically are absorbed into the blood 
stream and distributed throughout the host patient via the 
circulatory system, which can result in bacterial resistance. 
When administered locally, they limit the adverse effects 
of systemic administration and there is a higher concen-
tration of medication reaching the targeted site (Namazi, 
Kanani, 2009). 
The aim of the study is to examine the effect of 
stearic acid and sodium bicarbonate on the hydration and 
floatation behaviour, on the tableting properties as well as 
on the release profile of Methocel K4M matrices, using 
metronidazole as a model drug. The results will increase 
the actual knowledge about the goodness of this type of 
formulations for their processing as tablets. 
MATERIALS AND METHODS
Materials
The pharmaceutical excipients Methocel K4M, 
hydroxypropyl methylcellulose supplied by the Dow 
Chemical company, and the stearic acid and the drug me-
tronidazole obtained from Química Alkano Mexico, were 
used as received. The sodium bicarbonate was analytical 
grade from J. T. Baker-Mexico. 
Matrix preparation
As a previous step of the matrix preparation, the drug 
was pulverized 1 min. using an analytical mill at 20 000 
rpm (Tekmar A-10, Janke and Kunkel GmbH, Germany). 
The sodium bicarbonate was size reduced in a mortar for 
10 min. Stearic acid was sifted through a number 30 sie-
ve before it was used. The use of sodium bicarbonate is 
recommended at a relative humidity below 80%, to avoid 
decomposition (Kibbe, 2000). In this case, the matrices 
were always kept in two polyethylene bags, only as a 
precaution. The laboratory shows a relative humidity 
fluctuating between 38% and 65%.
Initially, matrix tablets were produced by using 
150 mg metronidazole and 450 mg Methocel K4M, for 
a total matrix weight of 600 mg. In this series of matrix 
tablets different quantities of the polymer content were 
substituted by stearic acid: 50, 100 y 150 mg per tablet, 
keeping the total tablet weight at 600 mg per tablet.
In a second series of matrix tablets 54 mg of the 
polymer content were substituted by sodium bicarbonate. 
The matrices were prepared with the same above mentio-
ned proportions of metronidazole and stearic acid.
Metronidazole, the polymer and sodium bicarbonate 
corresponding to 20 tablets were mixed for 20 min. There-
after, the stearic acid was added and the mixing continued 
for 10 min. Tablets were compressed in a hydraulic press 
fitted with flat faced 12.5 mm punch and die sets at a pres-
sure of 55 MPa during 10 seconds.
Compaction characteristics of the tablets
The tablets ejection pressure was determined follo-
wing their compaction, measuring the pressure necessary 
to eject the tablet from the die where it was compressed. 
The measurement was accomplished with hydraulic pres-
ses of different capacities added with manometers with 
red pointer.
The tablet hardness was measured using hydraulic 
presses similar to that above mentioned and was expressed 
as the pressure needed to fracture the tablets diametrically. 
Matrices hydration and floating time
Swelling was ascertained by measuring the axial and 
radial expansion of matrix tablets following exposure to 
dissolution medium. The dimensions of each matrix were 
measured using a dial caliper (General Tools, New York) 
prior to dissolution studies. Tablet hydration tests were 
performed using the same conditions described in the dis-
solution studies. At various time intervals the tablets were 
removed from the dissolution medium and measured in 
their dimensions using a microscope with digital camera 
(National Optical & Scientific Instruments, USA). The 
tablet volume was calculated considering a right circular 
cylinder form. The results for each time point of three 
repetitions are registered as an average.
The floating time was determined by observation of 
the floating behaviour throughout the dissolution studies 
and was registered as the average of 3 repetitions.
Drug release
Release data from swellable systems can be analyzed 
according to the power law expression shown in equation 
1. The kinetics and mechanism of drug release for each 
system was investigated by fitting the release data into this 
equation (Rinaki et al., 2003).
M
t
/M
inf
 = k * t n or ln (M
t
/M
inf
) = n * ln (t) + ln (k) (1)
The terms in this equation are as follows: M
t
, the 
amount of drug released at time t; M
inf
, the total drug rele-
ased over a long time period; k, the kinetics constant; and 
n, the mechanism of drug release. The value of n ranges 
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from 0.5 (t1/2 dependence, generally referred to as Fickian 
release) to 1 (representing the case II transport which is 
purely relaxation controlled). The values in between in-
dicate an anomalous behaviour corresponding to coupled 
diffusion/relaxation. When the value of n is greater than 
that of the case-II transport (n>1.0), the release is said to be 
Super case-II transport (Brazel, Peppas, 2000; Ranga Rao 
et al., 1988). In the case of a matrix with cylinder form, 
n is said to be 0.45 instead of 0.5 and 0.89 instead of 1.0 
(Kim, Fassihi, 1997).
Dissolution studies were performed in 900 ml of HCl 
0.1N using the paddle method (USP 26), at 50 rpm and 37 ºC 
(JT R09, TEMSA, Mexico). The amount of metronidazole 
released over time was determined by withdrawing samples 
at various time intervals. The concentration of metronidazo-
le was obtained by measuring its absorbance at 276 nm in a 
Beckman DU-650 ultraviolet spectrophotometer. 
The results for each time point of three different dis-
solution curves are registered as an average in the figures. 
These average values were used to calculate the regression 
parameters of each dissolution curve representing a given 
formula.
RESULTS AND DISCUSSION
Matrices floating time
Matrices made of Methocel K4M and stearic acid flo-
at more than 8 hours (Table I) while matrices without stearic 
acid float only 6 hours. The matrices floatability is attributed 
to the intrinsic Methocel properties and to a reduction of 
density produced by elevated quantities of the stearic acid 
which displays a true density of 0.980 g/cm3. The addition of 
54 mg of sodium bicarbonate per tablet allowed in all cases 
floating times greater than 8 hours (Table II).
The matrices behaviour is attributed to a relative rapid 
hydration of the external surface area of the Methocel K4M 
matrices, keeping for a longer time the original air bubbles 
that remain in the matrix after compression. The carbon 
dioxide bubbles, obtained after addition of sodium bicar-
bonate and its reaction with the acidic dissolution medium, 
produce a reinforcement of the matrix floatability. The car-
bon dioxide bubbles show a trend to disappear progressively 
with time as the matrix hydration progresses. However, the 
rapid gel formation on the matrices surface area contacting 
the dissolution medium reduces the speed of the bubbles 
disappearing through the gel layer. 
Compaction characteristics of the tablets
With the aim to establish a confident method to produ-
ce tablets it is convenient to examine the effect of addition 
of different proportions of the lubricant to metronidazole 
formulations, to reduce their adhesiveness to compaction 
tools. Although the usual proportions of the lubricant used 
in tablet formulation is in the range of 0.5-2.0%, in this case 
higher proportions were used with the purpose to observe 
its potential obstruction effect on the metronidazole dissolu-
TABLE I - Characteristics of Methocel K4M matrices containing 150 mg metronidazole and different proportions of stearic acid 
for a total matrix weight of 600 mg; compacted at 55 MPa
Stearic acid 
(mg/tablet) 
Pexp
(MPa) 
Tablet hardness 
(MPa) 
Floating time
(min)
Vmax
(mm3)
0 2.79 1.94 360 1894
50 1.17 1.16 >480 1861
100 1.00 1.80 >480 1819
150 1.02 0.86 >480 1469
Abbreviations: Pexp = Ejection pressure of the tablets; Vmax = Maximal hydration volume reached by matrices.
TABLE II - Characteristics of Methocel K4M matrices containing 150 mg metronidazole, 54 mg sodium bicarbonate and different 
proportions of stearic acid for a total matrix weight of 600 mg; compacted at 55 MPa
Stearic acid
(mg/tablet)
Pexp
(MPa)
Tablet hardness 
(MPa)
Floating time
(min)
Vmax
(mm3)
0 1.55 1.42 >480 1980
50 1.34 1.34 >480 1895
100 1.86 0.78 >480 2016
150 1.22 0.79 >480 1515
Abbreviations: Pexp = Ejection pressure of the tablets; Vmax = Maximal hydration volume reached by matrices.
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tion. This was studied as an additional effect of its properties 
to overcome the adhesive forces between the compaction 
tools and the matrix tablets (Kranz, Wagner, 2006). As can 
be seen in Tables I and II, the ejection pressure of Methocel 
matrices decreases progressively as the proportion of stearic 
acid in the formulation increases.
As expected from cellulose derivatives, the addition 
of stearic acid reduces the tablet hardness practically in 
the same proportion as it reduces the ejection pressure. 
However, in spite of a reduction of the tablet hardness up 
to 50%, the tablets are considered strong enough to permit 
their manipulation without problems.
Matrices hydration
Hydrophilic matrices immersed in water swell and 
eventually dissolve. When they are placed in water, swelling 
starts and the tablet thickness increases. Initially, water 
only diffuses through the polymeric matrix. As the polymer 
chains become more hydrated and the gel becomes more 
diluted the disentanglement concentration may be reached 
and the polymer chains detach from a gellified matrix. Thus, 
there is a slow diminution of the matrix thickness due to 
polymer dissolution. The polymer in the matrix undergoes 
simultaneously swelling, dissolution and diffusion into the 
bulk medium, resulting in reduction of strength and erosion 
of the matrix (Shott, 1992; Katzhendler et al., 1997; Kava-
nagh, Corrigan 2004).
As can be seen in Figures 1 and 2, the matrices hydra-
tion volume increases rapidly at the beginning, reaches a 
maximum, and then decline. While the polymer swelling 
progresses toward higher matrix volumes, the polymer 
dissolution produces the opposite. 
The addition of stearic acid to metronidazole/Methocel 
matrices, with and without sodium bicarbonate, reduces the 
hydration volume. This is attributed to a lessening of the poly-
mer proportion due to its partial substitution with stearic acid.
The addition of sodium bicarbonate to Methocel ma-
trices expands their volume due to gas bubbles formed after 
its reaction with the acidic dissolution medium. The average 
maximal volume reached by matrices with sodium bicar-
bonate during hydration (1851 mm3) is only to some extent 
greater than that reached by matrices without it (1760 mm3). 
However, it has to be considered that the addition of sodium 
bicarbonate means a reduction in the same magnitude in the 
polymer content, decreasing the matrices swelling capabi-
lity. The decrease in the polymer content is compensated 
by an expansion produced by the carbon dioxide bubbles. 
Moreover, the decrease of the swelling polymer as well as 
a minor consistency of matrices containing bicarbonate 
facilitates the matrix erosion. It is considered that the gas 
bubbles dissipating from the inside to the outside of the 
matrix debilitates the matrix structure. 
Release of metronidazole from Methocel K4M 
matrices
Release profiles of metronidazole from Methocel 
K4M matrices containing different proportions of stearic 
acid, fitting dissolution data into equation 1, produced 
FIGURE 1 - Hydration kinetics of matrices containing 150 mg 
metronidazole and variable quantities of Methocel K4M and 
stearic acid (SA), for a total matrix weight of 600 mg.
FIGURE 2 - Hydration kinetics of matrices containing 
metronidazole (150 mg), sodium bicarbonate (SB) (54 mg) and 
variable quantities of Methocel K4M and stearic acid (SA) for 
a total matrix weight of 600 mg.
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straight lines for data corresponding to drug release up to 8 
hours (Figures 3 and 4). The regression parameters obtained 
with equation 1 are registered in Tables III and IV. The effect 
of addition of lubricants such as stearic acid is expected to 
produce a lessening of drug dissolution as the proportion 
of the lubricant increases (Kranz, Wagner, 2006). However, 
here occurs the opposite. The effect of lessening the drug 
release with an increasing lubricant proportion, in a range of 
0.5-2.0%, can be ascribed to an increase of the hydrophobic 
nature of the matrix. On the other hand, the opposite effect 
of the same lubricant, at higher proportions (<25%), can 
be attributed to a decreased matrix coherence. This loss of 
coherence can be ascribed to a partial obstruction of the 
interparticle binding sites of the polymer particles giving 
shape to the matrix. Moreover, this can also be ascribed to a 
lesser polymer proportion, after it was substituted by greater 
lubricant proportions.
Although the differences observed by the different 
release profiles of matrices without bicarbonate are small 
(Figure 3), it is observed a clear trend toward greater quan-
tities of metronidazole dissolved as the stearic acid content 
of these matrices moves up. This trend is more noticeable 
in matrices containing sodium bicarbonate (Figure 4). 
Regardless of a greater dispersion of the dissolution data 
from matrices containing sodium bicarbonate, the avera-
ge standard error of k is 1.142 ±0.033 compared to 1.077 
±0.014 displayed by matrices without bicarbonate, this 
dispersion degree do not hide from view the effect of the 
carbon dioxide produced by sodium bicarbonate. 
At low proportions of stearic acid, it is observed a 
lessening of the metronidazole dissolved, ascribed to an 
FIGURE 3 - Release profiles of metronidazole (150 mg) from 
matrices containing variable quantities of stearic acid (SA) and 
Methocel K4M for a total matrix weight of 600 mg.
TABLE III - Regression parameters and the standard error (s. e.) of release profiles of metronidazole (150 mg) from Methocel K4M 
matrices containing different proportions of stearic acid, for a total matrix weight of 600 mg/tablet
Stearic acid
(mg/tablet) 
k
(± s. e.) 
n
(± e. t.)
Metro-8h 
(%)’
Metro-6h
(%)’
r2
0 3.644 ±1.0886 0.5366 ±0.0156 66.7 57.2 0.995
50 2.475 ±1.0569 0.6112 ±0.0113 71.8 60.2 0.998
100 4.593 ±1.0717 0.5068 ±0.0131 69.9 60.5 0.995
150 5.340 ±1.0891 0.4850 ±0.0162 71.1 61.8 0.992
Abbreviations: k = Kinetics or release constant; n = exponent indicative of the release mechanism; Metro-8h (6h) = calculated 
metronidazole dissolution after 8 hours (6 hours).
TABLE IV - Regression parameters and the standard error (s.e.) of release profiles of metronidazole (150 mg) from Methocel K4M 
matrices containing 54 mg sodium bicarbonate and different proportions of stearic acid, for a total matrix weight of 600 mg/tablet
Stearic acid
(mg/tablet) 
k
(± e. t.) 
n
(± e. t.) 
Metro-8h
(%)’
Metro-6h
(%)’
r2
0 5.182 ±1.136 0.4601 ±0.0241 59.2 51.8 0.981
50 3.013 ±1.103 0.5276 ±0.0187 52.2 44.8 0.991
100 3.524 ±1,182 0.5183 ±0.0318 57.6 49.6 0.974
150 7.946 ±1.149 0.4258 ±0.0264 73.4 64.9 0.974
Abbreviations: k = Kinetics or release constant; n = exponent indicative of the release mechanism; Metro-8h (6h) = calculated 
metronidazole dissolution after 8 hours (6 hours).
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increase in the hydrophobic nature of the matrix. However, 
at higher proportions of the lubricant an effect of obstruc-
tion of the interparticle bonds of the polymer particles 
giving shape to the matrix prevails over the above men-
tioned effect. This produces an increase of the dissolution 
rate of metronidazole.
On the other hand, matrices containing sodium 
bicarbonate show expanded differences in the release 
profiles. The presence of sodium bicarbonate, at low 
proportions of stearic acid, reduces the release rate of the 
drug while at higher proportions of stearic acid it increases.
The above mentioned can be explained because of 
a partial obstruction of the diffusion path caused by the 
carbon dioxide bubbles dispersed in the matrix. The pre-
sence of the gas bubbles slows down the water transport 
in the direction of the matrix as well as the transport of the 
dissolved metronidazole towards the outside of the matrix. 
However, the matrix expansion effect caused by the same 
bubbles debilitates the matrix structure, increasing its 
volume. This allows a recovery and increase of the drug 
dissolution in matrices containing 150 mg stearic acid. The 
expansion of the matrix produced by carbon dioxide makes 
evident the reduction of the matrix coherence produced by 
stearic acid. This means, the carbon dioxide bubbles make 
more evident the strength or the weakness of a matrix, 
produced by the presence of stearic acid.
Figures 5 and 6 show the increase of the release cons-
tant values after addition of stearic acid. The predominant 
effect of stearic acid would be that of obstruction of the 
interparticles bonds of the polymer particles, decreasing 
the matrix coherence and facilitating the matrix expansion 
from the very beginning. All this contributes to increase 
the drug dissolution. In the same way, the figures also 
show decreasing values of the exponent indicative of the 
release mechanism of metronidazole as the proportion of 
stearic acid increases. The last statement can be explained 
in terms of the possibilities for relaxation or expansion of 
these matrices. A matrix with a high proportion of stearic 
acid, having a lower coherence, relaxes faster. Because 
of this, its capability to relax further with time is lesser. A 
matrix that relaxes slowly release the drug basically by di-
ffusion through the water filled pores. This circumstance is 
expressed as lower values of the exponent indicative of the 
release mechanism (n). Then again, a matrix with a lower 
proportion of stearic acid displays a greater coherence due 
to a greater binding surface area of the polymer particles 
one with each other. This greater matrix coherence permits 
only a lesser relaxation or swelling speed. The swelling and 
relaxation processes take a longer time, increasing gradually 
the volume of the water filled pores and with this, increase 
the drug release rate. This circumstance is expressed as 
greater values of the exponent (n). This points out to a 
release mechanism moving gradually from a mechanism 
predominantly controlled by diffusion towards a mechanism 
with a greater contribution of the matrix relaxation process.
The swelling of the polymer particles produces an 
expansion that sources a more noticeable matrix relaxation 
when the polymer particles are strongly bonded. Weak or less 
strong interparticles bonds, for instance produced by greater 
proportions of a lubricant, favour a less coherent structure 
FIGURE 4 - Release profiles of metronidazole (150 mg) from 
matrices containing 54 mg sodium bicarbonate (SB) and variable 
quantities of stearic acid (SA) and Methocel K4M for a total 
matrix weight of 600 mg.
FIGURE 5 - Effect of stearic acid on the regression parameters 
of metronidazole (150 mg) release profiles from Methocel K4M 
matrices with a total weight of 600 mg.
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from the very beginning. In this sense, a further relaxation 
because of polymer swelling is less noticeable. Matrices with 
lower stearic acid proportions display a release mechanism 
with a greater contribution of matrix relaxation, compared to 
matrices containing greater lubricant proportions. 
CONCLUSION
Although Methocel is not a polymer showing a strong 
adhesion to compaction tools some other components of a 
formulation can make necessary the addition of a lubricant to 
smooth the progress of the fabrication process. Stearic acid is 
used to reduce the tablet ejection pressure up to a reasonable 
level for production, despite the fact that it also reduces the 
tablet hardness. Even so, it is considered that the tablet hard-
ness can be still satisfactory to manipulate the matrix tablets 
without problems or physical deterioration. 
The matrices hydration kinetics shows a quadratic 
relationship with respect to time. This relationship is attribu-
ted to a simultaneous matrix swelling and erosion. Initially, 
it is observed an increase of hydration volume, reaching a 
maximum that declines thereafter. The matrices hydration 
volume is directly related to the matrix polymer proportion. 
It means that a decrease of the polymeric phase, as a conse-
quence of its substitution by stearic acid, corresponds to a 
reduction of the matrix hydration volume. The addition of 
sodium bicarbonate, with the corresponding reduction of the 
polymeric phase, may well be associated with a reduction of 
the hydration volume. However, this is not the case. There is 
a recovery and eventually an increase of the hydration volu-
me as a consequence of a matrix expansion produced by the 
generation of gas bubbles in the hydrated gel layer.
With respect of the method used to determine the ejec-
tion pressure, the tablet hardness and the hydration volume, 
they have to be improved to get a better confidence level on 
the obtained results.
The floating properties of hydrophilic matrices depend 
first of all of the intrinsic properties of the polymer, properties 
that can be modified with some other added excipients. The 
characteristic of Methocel to form rapidly a gel layer on the 
matrix surface area contacting an aqueous medium allows the 
preservation or the delay of the dissipation of the original air 
bubbles or the created carbon dioxide bubbles. This makes 
possible the matrices floatation.
Stearic acid behaves as an inert material that modifies 
the metronidazole dissolution. Metronidazole dissolution in-
creases with increasing proportions of stearic acid, associated 
to decreasing proportions of the matrix polymer content. This 
effect seems to be related to a reduction of the dissolution 
restricting phase, the polymeric material, and to the obstruc-
tion of the interparticle bonds of the polymeric phase. The 
presence of sodium bicarbonate produces carbon dioxide 
bubbles. These bubbles obstruct the transport throughout the 
matrix, reducing the drug dissolution rate, in spite of a lesser 
proportion of the polymeric phase. However, these bubbles 
also enlarge the matrix volume, allowing an increase in the 
drug release rate.
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